The nonmutant allele of the BRCA1 gene helps to suppress tumor formation in women who are heterozygous for the mutation. Women heterozygous for BRCA1 nevertheless have a 50% to 70% chance of developing breast cancer before age 70, and the usual reason is that the nonmutant allele is lost or inactivated in a lineage of cells. One possible mechanism for such "loss of heterozygosity" is:
A. germ cells in the affected individual develop a mutation in the nonmutant allele of BRCAL.
B. a somatic mutation in a breast cell inactivates the nonmutant BRCA1 allele.
C. a silent mutation occurs in the nonmutant BRCA1 allele.